Gedeon Richter and Myovant Sciences Receive Positive CHMP Opinion for RYEQO® (Relugolix Combination Tablet) for the Treatment of Uterine Fibroids
5/21/2021
Business related Marketing authorization application PARTNER - MYOVANT PRODUCT - RYEQO Women's Healthcare
509 kb 5/21/2021 pdf